253 related articles for article (PubMed ID: 19101104)
21. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
[TBL] [Abstract][Full Text] [Related]
22. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
[TBL] [Abstract][Full Text] [Related]
23. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
Iagaru A; Quon A; McDougall IR; Gambhir SS
Clin Nucl Med; 2006 Dec; 31(12):754-60. PubMed ID: 17117068
[TBL] [Abstract][Full Text] [Related]
24. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
25. Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics.
Chen Z; Li X; Li F; Ouyang Q; Yu T
Eur J Radiol; 2010 Sep; 75(3):329-35. PubMed ID: 20576385
[TBL] [Abstract][Full Text] [Related]
26. Postoperative FDG-PET/CT staging in GIST: is there a benefit following R0 resection?
Hahn S; Bauer S; Heusner TA; Ebeling P; Hamami ME; Stahl A; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Dec; 80(3):670-4. PubMed ID: 20970938
[TBL] [Abstract][Full Text] [Related]
27. Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck.
Deron P; Mertens K; Goethals I; Rottey S; Duprez F; De Neve W; Vermeersch H; Van de Wiele C
Nuklearmedizin; 2011; 50(4):141-6. PubMed ID: 21594304
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET/CT in the evaluation of POEMS syndrome.
Albertí MA; Martinez-Yélamos S; Fernandez A; Vidaller A; Narváez JA; Cano LM; Gamez C; Martinez-Matos JA
Eur J Radiol; 2010 Nov; 76(2):180-2. PubMed ID: 19581061
[TBL] [Abstract][Full Text] [Related]
29. Does positron emission tomography data acquisition impact simultaneous diffusion-weighted imaging in a whole-body PET/MRI system?
Buchbender C; Hartung-Knemeyer V; Heusch P; Heusner TA; Beiderwellen K; Wittsack HJ; Kühl H; Forsting M; Bockisch A; Antoch G; Lanzman RS
Eur J Radiol; 2013 Feb; 82(2):380-4. PubMed ID: 23238361
[TBL] [Abstract][Full Text] [Related]
30. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
[TBL] [Abstract][Full Text] [Related]
31. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
32. Special Techniques in PET/Computed Tomography Imaging for Evaluation of Head and Neck Cancer.
Kumar R; Mukherjee A; Mittal BR
PET Clin; 2016 Jan; 11(1):13-20. PubMed ID: 26590440
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous endoscopic gastrostomy site metastases in head and neck cancer: use of FDG PET-CT.
Purandare NC; Rangarajan V; Sharma AR; Shah S; Singh N; Arora A; Pathak S; Deshpande M
Diagn Interv Radiol; 2008 Jun; 14(2):88-93. PubMed ID: 18553282
[TBL] [Abstract][Full Text] [Related]
34. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
Kawata S; Imaizumi M; Kako Y; Oku N
Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
[TBL] [Abstract][Full Text] [Related]
35. Role of limited whole-body PET/CT in pediatric lymphoma.
Sammer MB; Shulkin BL; Alessio A; Parisi MT
AJR Am J Roentgenol; 2011 May; 196(5):1047-55. PubMed ID: 21512070
[TBL] [Abstract][Full Text] [Related]
36. Relationship between a chronically painful trapezius muscle and its metabolic state analyzed with PET/CT.
Takiguchi S; Maekawa K; Ono T; Sasai N; Kaji M; Clark GT; Kuboki T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul; 110(1):54-61. PubMed ID: 20610298
[TBL] [Abstract][Full Text] [Related]
37. 18 FDG PET and PET-CT for the detection of bone metastases in patients with head and neck cancer. A meta-analysis.
Yi X; Fan M; Liu Y; Zhang H; Liu S
J Med Imaging Radiat Oncol; 2013 Dec; 57(6):674-9. PubMed ID: 24283555
[TBL] [Abstract][Full Text] [Related]
38. [[F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT].
Dresel S; Schwenzer K; Brinkbäumer K; Schmid R; Szeimies U; Pöpperl G; Hahn K
Nuklearmedizin; 2001 Oct; 40(5):172-8. PubMed ID: 11727630
[TBL] [Abstract][Full Text] [Related]
39. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
[TBL] [Abstract][Full Text] [Related]
40. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL
Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]